rewirebio.iobenchmarks
Configuration

Octopus v0.7.4, tumour-only, Illumina (Chen et al. 2025)

Octopus v0.7.4, tumour-only, Illumina: Tumour-only run with the authors' recommended settings.

2 evaluations · 14 results

Overview

An explanatory profile has not yet been reviewed for this record.

Consult the linked sources for architecture or protocol details. Missing evidence is not evidence of a missing capability.

Evaluations and results

2 evaluations · 14 results. Different protocols are not a single leaderboard.

Dataset: COLO829 tumour Illumina NovaSeq 6000 WGS (ClairS-TO benchmark)

Sorted by AUPRC (indel only, tumour-only, 50x tumour coverage) (higher is better). The best value in each column is highlighted. Decimals are rounded for display; each value links to the printed value and its source.

Tested configurationProtocol and datasetAUPRC (indel only, tumour-only, 50x tumour coverage)AUPRC (SNV only, tumour-only, 50x tumour coverage)F1 (indel only, tumour-only, 50x tumour coverage, at the best-F1 threshold)F1 (SNV only, tumour-only, 50x tumour coverage, at the best-F1 threshold)False negatives (indel only, tumour-only, 50x tumour coverage, at the best-F1 threshold)False negatives (SNV only, tumour-only, 50x tumour coverage, at the best-F1 threshold)False positives (indel only, tumour-only, 50x tumour coverage, at the best-F1 threshold)False positives (SNV only, tumour-only, 50x tumour coverage, at the best-F1 threshold)Precision (indel only, tumour-only, 50x tumour coverage, at the best-F1 threshold)Precision (SNV only, tumour-only, 50x tumour coverage, at the best-F1 threshold)Recall (indel only, tumour-only, 50x tumour coverage, at the best-F1 threshold)Recall (SNV only, tumour-only, 50x tumour coverage, at the best-F1 threshold)True positives (indel only, tumour-only, 50x tumour coverage, at the best-F1 threshold)True positives (SNV only, tumour-only, 50x tumour coverage, at the best-F1 threshold)
Octopus v0.7.4, tumour-only, Illumina (Chen et al. 2025)EvaluationIllumina COLO829 tumour-only, 50x, somatic indels (Chen et al. 2025 Supplementary Table 7b)0.0044Not reported0.0096Not reported609Not reported20,809Not reported0.005Not reported0.146Not reported104Not reported
Octopus v0.7.4, tumour-only, Illumina (Chen et al. 2025)EvaluationIllumina COLO829 tumour-only, 50x, somatic SNVs (Chen et al. 2025 Supplementary Table 7b)Not reported0.212Not reported0.403Not reported9,792Not reported80,410Not reported0.275Not reported0.757Not reported30,440
All 14 result rows with coverage, uncertainty and sources
Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Configuration: Octopus v0.7.4, tumour-only, Illumina (Chen et al. 2025)Protocol: Illumina COLO829 tumour-only, 50x, somatic indels (Chen et al. 2025 Supplementary Table 7b)
Dataset: COLO829 tumour Illumina NovaSeq 6000 WGS (ClairS-TO benchmark)
0.0044 AUPRC (indel only, tumour-only, 50x tumour coverage)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Octopus on illumina-colo829 tumour-only Indel (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-illumina-colo829-indel

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 7b, Dataset 'COLO829', Caller 'Octopus', Tumor coverage '50x', Type 'Indel', column 'AUPRC'
Configuration: Octopus v0.7.4, tumour-only, Illumina (Chen et al. 2025)Protocol: Illumina COLO829 tumour-only, 50x, somatic indels (Chen et al. 2025 Supplementary Table 7b)
Dataset: COLO829 tumour Illumina NovaSeq 6000 WGS (ClairS-TO benchmark)
0.0096 F1 (indel only, tumour-only, 50x tumour coverage, at the best-F1 threshold)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Octopus on illumina-colo829 tumour-only Indel (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-illumina-colo829-indel

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 7b, Dataset 'COLO829', Caller 'Octopus', Tumor coverage '50x', Type 'Indel', column 'F1-score'
Configuration: Octopus v0.7.4, tumour-only, Illumina (Chen et al. 2025)Protocol: Illumina COLO829 tumour-only, 50x, somatic indels (Chen et al. 2025 Supplementary Table 7b)
Dataset: COLO829 tumour Illumina NovaSeq 6000 WGS (ClairS-TO benchmark)
609 False negatives (indel only, tumour-only, 50x tumour coverage, at the best-F1 threshold)
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Octopus on illumina-colo829 tumour-only Indel (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-illumina-colo829-indel

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 7b, Dataset 'COLO829', Caller 'Octopus', Tumor coverage '50x', Type 'Indel', column 'FN'
Configuration: Octopus v0.7.4, tumour-only, Illumina (Chen et al. 2025)Protocol: Illumina COLO829 tumour-only, 50x, somatic indels (Chen et al. 2025 Supplementary Table 7b)
Dataset: COLO829 tumour Illumina NovaSeq 6000 WGS (ClairS-TO benchmark)
20,809 False positives (indel only, tumour-only, 50x tumour coverage, at the best-F1 threshold)
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Octopus on illumina-colo829 tumour-only Indel (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-illumina-colo829-indel

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 7b, Dataset 'COLO829', Caller 'Octopus', Tumor coverage '50x', Type 'Indel', column 'FP'
Configuration: Octopus v0.7.4, tumour-only, Illumina (Chen et al. 2025)Protocol: Illumina COLO829 tumour-only, 50x, somatic indels (Chen et al. 2025 Supplementary Table 7b)
Dataset: COLO829 tumour Illumina NovaSeq 6000 WGS (ClairS-TO benchmark)
0.005 Precision (indel only, tumour-only, 50x tumour coverage, at the best-F1 threshold)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Octopus on illumina-colo829 tumour-only Indel (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-illumina-colo829-indel

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 7b, Dataset 'COLO829', Caller 'Octopus', Tumor coverage '50x', Type 'Indel', column 'Precision'
Configuration: Octopus v0.7.4, tumour-only, Illumina (Chen et al. 2025)Protocol: Illumina COLO829 tumour-only, 50x, somatic indels (Chen et al. 2025 Supplementary Table 7b)
Dataset: COLO829 tumour Illumina NovaSeq 6000 WGS (ClairS-TO benchmark)
0.146 Recall (indel only, tumour-only, 50x tumour coverage, at the best-F1 threshold)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Octopus on illumina-colo829 tumour-only Indel (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-illumina-colo829-indel

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 7b, Dataset 'COLO829', Caller 'Octopus', Tumor coverage '50x', Type 'Indel', column 'Recall'
Configuration: Octopus v0.7.4, tumour-only, Illumina (Chen et al. 2025)Protocol: Illumina COLO829 tumour-only, 50x, somatic indels (Chen et al. 2025 Supplementary Table 7b)
Dataset: COLO829 tumour Illumina NovaSeq 6000 WGS (ClairS-TO benchmark)
104 True positives (indel only, tumour-only, 50x tumour coverage, at the best-F1 threshold)
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Octopus on illumina-colo829 tumour-only Indel (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-illumina-colo829-indel

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 7b, Dataset 'COLO829', Caller 'Octopus', Tumor coverage '50x', Type 'Indel', column 'TP'
Configuration: Octopus v0.7.4, tumour-only, Illumina (Chen et al. 2025)Protocol: Illumina COLO829 tumour-only, 50x, somatic SNVs (Chen et al. 2025 Supplementary Table 7b)
Dataset: COLO829 tumour Illumina NovaSeq 6000 WGS (ClairS-TO benchmark)
0.212 AUPRC (SNV only, tumour-only, 50x tumour coverage)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Octopus on illumina-colo829 tumour-only SNV (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-illumina-colo829-snv

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 7b, Dataset 'COLO829', Caller 'Octopus', Tumor coverage '50x', Type 'SNV', column 'AUPRC'
Configuration: Octopus v0.7.4, tumour-only, Illumina (Chen et al. 2025)Protocol: Illumina COLO829 tumour-only, 50x, somatic SNVs (Chen et al. 2025 Supplementary Table 7b)
Dataset: COLO829 tumour Illumina NovaSeq 6000 WGS (ClairS-TO benchmark)
0.403 F1 (SNV only, tumour-only, 50x tumour coverage, at the best-F1 threshold)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Octopus on illumina-colo829 tumour-only SNV (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-illumina-colo829-snv

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 7b, Dataset 'COLO829', Caller 'Octopus', Tumor coverage '50x', Type 'SNV', column 'F1-score'
Configuration: Octopus v0.7.4, tumour-only, Illumina (Chen et al. 2025)Protocol: Illumina COLO829 tumour-only, 50x, somatic SNVs (Chen et al. 2025 Supplementary Table 7b)
Dataset: COLO829 tumour Illumina NovaSeq 6000 WGS (ClairS-TO benchmark)
9,792 False negatives (SNV only, tumour-only, 50x tumour coverage, at the best-F1 threshold)
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Octopus on illumina-colo829 tumour-only SNV (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-illumina-colo829-snv

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 7b, Dataset 'COLO829', Caller 'Octopus', Tumor coverage '50x', Type 'SNV', column 'FN'
Configuration: Octopus v0.7.4, tumour-only, Illumina (Chen et al. 2025)Protocol: Illumina COLO829 tumour-only, 50x, somatic SNVs (Chen et al. 2025 Supplementary Table 7b)
Dataset: COLO829 tumour Illumina NovaSeq 6000 WGS (ClairS-TO benchmark)
80,410 False positives (SNV only, tumour-only, 50x tumour coverage, at the best-F1 threshold)
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Octopus on illumina-colo829 tumour-only SNV (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-illumina-colo829-snv

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 7b, Dataset 'COLO829', Caller 'Octopus', Tumor coverage '50x', Type 'SNV', column 'FP'
Configuration: Octopus v0.7.4, tumour-only, Illumina (Chen et al. 2025)Protocol: Illumina COLO829 tumour-only, 50x, somatic SNVs (Chen et al. 2025 Supplementary Table 7b)
Dataset: COLO829 tumour Illumina NovaSeq 6000 WGS (ClairS-TO benchmark)
0.275 Precision (SNV only, tumour-only, 50x tumour coverage, at the best-F1 threshold)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Octopus on illumina-colo829 tumour-only SNV (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-illumina-colo829-snv

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 7b, Dataset 'COLO829', Caller 'Octopus', Tumor coverage '50x', Type 'SNV', column 'Precision'
Configuration: Octopus v0.7.4, tumour-only, Illumina (Chen et al. 2025)Protocol: Illumina COLO829 tumour-only, 50x, somatic SNVs (Chen et al. 2025 Supplementary Table 7b)
Dataset: COLO829 tumour Illumina NovaSeq 6000 WGS (ClairS-TO benchmark)
0.757 Recall (SNV only, tumour-only, 50x tumour coverage, at the best-F1 threshold)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Octopus on illumina-colo829 tumour-only SNV (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-illumina-colo829-snv

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 7b, Dataset 'COLO829', Caller 'Octopus', Tumor coverage '50x', Type 'SNV', column 'Recall'
Configuration: Octopus v0.7.4, tumour-only, Illumina (Chen et al. 2025)Protocol: Illumina COLO829 tumour-only, 50x, somatic SNVs (Chen et al. 2025 Supplementary Table 7b)
Dataset: COLO829 tumour Illumina NovaSeq 6000 WGS (ClairS-TO benchmark)
30,440 True positives (SNV only, tumour-only, 50x tumour coverage, at the best-F1 threshold)
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Octopus on illumina-colo829 tumour-only SNV (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-illumina-colo829-snv

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 7b, Dataset 'COLO829', Caller 'Octopus', Tumor coverage '50x', Type 'SNV', column 'TP'

Source checking is not independent reproduction. Release 2026-10-22-1b7cf027e4f6.

Use this configuration

How it works, versions and access
Strengths, limitations and unresolved questions

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

0 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-10-22-1b7cf027e4f6
Property and statementOriginal source and locationReview and provenance

No evidence rows match these filters. Choose another scope or clear the search.

Sources and history

Release 2026-10-22-1b7cf027e4f6 · Record review: source checked

3 source records and release historyDownload this release (gzip)
Technical metadata and extraction receipts

Stable ID: somatic-clairs-to-20261011-config-octopus-illumina

areas
dna-genomes
contexts
clinical_research
method types
conventional_pipeline
reported name
Octopus
version
v0.7.4
foundation model eligible
false
parameters
Tumour-only run with the authors' recommended settings (Supplementary Information command lines)
access reuse
Public open-source software and released models
source locator
Supplementary Information 'Command lines used'; Supplementary Tables 2 and 7 row labels
provenance note
Octopus as run on Illumina tumour-only data in the cited comparison.
Related records

Suggest a correction